Sunday, February 15, 2026 2/15/2026

Developing nanobody immune libraries against native neuronal nicotinic receptor complexes

Award Number: R03DA055205
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2023
PERIOD OF PERFORMANCE END DATE: 04/30/2025

Group Awards By:

View Award Description

Developing nanobody immune libraries against native neuronal nicotinic receptor complexes - ABSTRACT Nicotinic acetylcholine receptors are ubiquitous in the brain and underlie regulation of attention and arousal by cholinergic neurons. nAChRs are highly expressed in neurons of the reinforcement and reward pathways, and maladaptive effects on nAChRs resulting from drug exposure contribute to drug addiction. These receptors are crucial in addiction both to nicotine (a direct orthosteric agonist of nAChRs) and to other drugs of abuse resulting from drug induced plastic changes in cholinergic activity in reward centers. A persistent challenge facing any nAChR-targeted pharmaceutical approach against addiction is the broad diversity in assembly and distribution of the brain-expressed forms of the protein. The long-term goal of this project is to develop an accurate and comprehensive methodology to identify and therapeutically target the full family of native nAChR conformations. The short-term goal of this R03 proposal is to demonstrate that a yeast-display nanobody library, screened against two distinct, widely expressed and physiologically critical conformations of nAChRs, will demonstrate the ability to robustly parse two separate stoichiometries of the nAChR in in vitro fluorescence and electrophysiology assays. The rationale is to deliver proof-of-concept that this approach can specifically target individual receptor types, to stimulate further characterization of successfully identified reagents for their possible functionality in modifying nAChR activity, and ultimately to establish the approach as a feasible method to study the native expression and assembly properties of the entire family of native nAChRs. This study includes two related objectives: 1) to develop a nanobody library enriched for yeast-mounted variable domain modules that potently bind purified 42 nAChRs and 2) to establish an effective counter-screening assay to deplete stoichiometrically non-specific nanobodies to purify interactors that selectively target two physiologically relevant, structurally distinct assemblies of 42. This represents an innovative application of the cutting-edge yeast nanobody screening method against a persistent roadblock in understanding the maladaptive changes to nicotinic receptor protein expression and distribution. Development and delivery of a biologic toolbox to study and manipulate all native nAChRs in vivo, as is the overall goal of this research, would represent a significant biomedical advance to investigate and combat addiction and other human ailments associated with the cholinergic nervous system.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$165 )
2025	2024	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Drug Use and Addiction Research Programs	000	2	9/4/2025	NON-COMPETING CONTINUATION	-$165
														Subtotal = -$165

Issue Date FY: 2024 ( Subtotal = $79,950 )
2024	2024	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Drug Use and Addiction Research Programs	000	2	4/11/2024	NON-COMPETING CONTINUATION	$79,950
														Subtotal = $79,950

Issue Date FY: 2023 ( Subtotal = $79,950 )
2023	2023	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Drug Use and Addiction Research Programs	000	1	4/24/2023	NEW	$79,950
														Subtotal = $79,950

Grand Total All Awards = $159,735

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Developing nanobody immune libraries against native neuronal nicotinic receptor complexes

Award Number: R03DA055205

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2023

PERIOD OF PERFORMANCE END DATE: 04/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer